NasdaqGS - Nasdaq Real Time Price USD
Spyre Therapeutics, Inc. (SYRE)
15.31
+0.43
+(2.89%)
As of 3:17:47 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -0.7 | -0.75 | -2.9 | -3.15 |
| Low Estimate | -0.83 | -0.87 | -3.45 | -4.27 |
| High Estimate | -0.62 | -0.55 | -2.23 | -2.46 |
| Year Ago EPS | -0.86 | -1.36 | -3.18 | -2.9 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.91 | -0.86 | -0.94 | -0.84 |
| EPS Actual | -0.86 | -1.36 | -0.81 | -0.6 |
| Difference | 0.05 | -0.5 | 0.13 | 0.24 |
| Surprise % | 5.49% | -57.77% | 14.22% | 28.57% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.7 | -0.75 | -2.9 | -3.15 |
| 7 Days Ago | -0.74 | -0.76 | -2.82 | -3.46 |
| 30 Days Ago | -0.84 | -0.88 | -3.46 | -3.67 |
| 60 Days Ago | -0.84 | -0.88 | -3.48 | -3.74 |
| 90 Days Ago | -1.02 | -0.94 | -4.14 | -5.31 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 6 | 5 | -- | 2 |
| Up Last 30 Days | 6 | 5 | 6 | 6 |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SYRE | 18.75% | 45.13% | 8.92% | -8.76% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 4/8/2025 |
| Initiated | Jones Trading: Hold | 12/11/2024 |
| Maintains | Baird: Outperform to Outperform | 11/13/2024 |
| Maintains | Guggenheim: Buy to Buy | 10/25/2024 |
| Initiated | Wedbush: Outperform | 9/4/2024 |
| Initiated | Evercore ISI Group: Outperform | 7/16/2024 |
Related Tickers
ORKA Oruka Therapeutics, Inc.
10.60
+2.81%
PHVS Pharvaris N.V.
16.65
-0.27%
APGE Apogee Therapeutics, Inc.
39.80
-0.28%
DNTH Dianthus Therapeutics, Inc.
18.74
-2.78%
UPB Upstream Bio, Inc.
9.25
+2.15%
ELVN Enliven Therapeutics, Inc.
17.28
+2.55%
TCRX TScan Therapeutics, Inc.
1.2200
-1.60%
SRZN Surrozen, Inc.
8.01
-0.25%
MBX MBX Biosciences, Inc.
12.00
-1.23%
CGEM Cullinan Therapeutics, Inc.
7.89
+2.33%